Abstract
Osteocalcin(OC) is a specific serum parameter of bone formation. Since bone metabolism disturbances, including osteoporosis, are seen in paraplegia, the serum levels of OC, midregional parathyroid hormone(mPTH), intact parathyroid hormone (iPTH) and calcitonin (CT) serum levels were determined in 13 patients with paraplegia or tetraplegia and 15 control subjects by radioimmunoassay in a cross sectional study. In addition, the urinary hydroxyproline/creatine and the urinary calcium/creatinine ratio was determined. Serum OC levels were significantly increased in the patients with spinal cord injury (p < 0.02), whereas serum levels of mPTH, iPTH and CT were not statistically different.
The urinary hydroxproline/creatinine ratio was significantly higher in the patients than in the controls (p < 0.02), and the urinary calcium/creatinine ratio also tended to be higher in the patients. In a follow up study over 6 months after spinal cord injury, serum OC, serum iPTH, urinary hydroxyproline/creati-nine ratio and the calcium/creatinine ratio were determined in 6 patients at monthly intervals. Hyperhydroxyprolinuria preceded the gradual increase of serum OC from normal to clearly elevated levels. Our data suggest that increased bone resorption in paraplegia is linked to an enhanced osteoblastic activity.
Similar content being viewed by others
Article PDF
References
Claus-Walker J, Carter R E, Campos R J, Spencer W A (1975) Hyper-calcemia in early traumatic quadriplegia. J Chron Dis 28: 81–90.
Chantraine A (1978) Actual concept of osteoporosis in paraplegia. Paraplegia 16: 51–58.
Steinberg F U, Birge S J, Cooke N E (1978) Hypercalcaemia in adolescent tetraplegic patients: case report and review. Paraplegia 16: 60–67.
Chantraine A, Heynen G, Franchimont P (1979) Bone metabolism, parathyroid hormone and calcitonin in paraplegia. Calif Tiss Int 27: 199–204.
Price P A, Parthemore J G, Deftos L J (1980) New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 66: 878–883.
Garcia-Carrasco M, Gruson M, de Vernejoul M C, Denne A, Miravet L (1988) Osteocalcin and bone morphometric parameters in adults without bone disease. Calif Tiss Int 42: 13–17.
Brown J P, Delmas P D, Malaval L, Edouard C, Chapuy M C, Meunier P J (1984) Serum bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1: 1091–1093.
Lukert B P, Higgins J C, Stoskopf M M (1986) Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 62: 1056–1058.
Nussbaum S R, Zahradnik R J, Lavigne J R, Brennan G L, Nozawa-Ung K, Kim L Y, Kentmann H T, Wang C A, Potts J T, Segre G V (1988) Highly sensitive two site immunoradiometric assay of parathyrine and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33: 1364–1367.
Neill H B, Palmieri G M, Neely C L, McDonald M W (1981) Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer. Arch Intern Med 141: 1471–1473.
Goverde B C, Veenkamp F J N (1972) Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysis. Clin Chim Acta 41: 29–40.
Stepan J J, Pospichal J, Presl J, Pacovsky V (1989) Prospective trial of ossein-hydroxyapatite compound in surgically induced postmenopausal women. Bone 10: 179–185.
Naftchi N E (1985) Alterations of neuroendocrine functions in spinal cord injury. Peptides 6(suppl 1): 85–94.
Stewart A F, Adler M, Byers C M, Segre G V, Broadus A E (1982) Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 306: 1136–1140.
Arnaud S B, Schneider V S, Morey-Holton E (1986) Effects of inactivity on bone and calcium metabolism. In: Sandier H, Vernikos J, editors. Inactivity: Physiological Effects, Academic Press Inc: 49–76.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pietschmann, P., Pils, P., Woloszczuk, W. et al. Increased serum osteocalcin levels in patients with paraplegia. Spinal Cord 30, 204–209 (1992). https://doi.org/10.1038/sc.1992.56
Issue Date:
DOI: https://doi.org/10.1038/sc.1992.56
Keywords
This article is cited by
-
Deterioration of trabecular bone microarchitecture in the lumbar vertebrae in growing male mice following sciatic neurectomy
International Journal of Precision Engineering and Manufacturing (2014)
-
Strontium Ranelate Prevents Bone Loss in a Rat Model of Localized Muscle Paralysis
Annals of Biomedical Engineering (2012)
-
Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury
Osteoporosis International (2011)
-
Bone loss and impaired fracture healing in spinal cord injured mice
Osteoporosis International (2011)
-
Osteoporosis after spinal cord injury
Osteoporosis International (2006)